Lactobacillus and Bacillus probiotics may serve as an alternative to antibiotics in milk replacer for pre-ruminant calves by altering gastrointestinal microflora to prevent the proliferation of harmful bacteria. However, there are limited studies evaluating their impact on calf growth and efficiency. The objective of this trial was to discover the impact of probiotic-containing milk replacer on pre-ruminating calf growth performance. A total of 44 pre-ruminant calves (50% Angus/50% Holstein, average weight 39.3 kg + 7.5 kg) were fed milk replacer with either no probiotic or 1.25x10^9 colony forming units/head/day of a probiotic blending containing Lactobacillus and two different Bacillus species (Church & Dwight Animal Nutrition (Princeton, NJ). Calves were blocked by age and randomly assigned within block to one of two treatments in a randomized complete block design. Calf was the experimental unit, with 22 calves per treatment. Calf weight and hip height was measured on d 0 and 30 to calculate average daily gain (ADG) and average growth per day. Calves were offered 1.36 kg milk replacer [15% dry matter (DM)] twice daily and up to 0.5 kg starter feed (88% DM) once daily. Refusals were recorded to calculate average daily intake and gain to feed ratio (G:F). Initial weight differed (P = 0.020) between treatments, and was therefore used as a covariate in all response criteria. Calves fed milk replacer with probiotic had greater (P < 0.05) ADG (0.53 vs. 0.42 kg/d, respectively) and G:F (0.50 vs. 0.41, respectively) than those fed the control. There was no evidence (P >0.05) that probiotic inclusion impacted hip height on d 30 or daily intake. In summary, Lactobacillus and Bacillus probiotic inclusion in milk replacer improved calf growth performance without impacting intake. Subsequent research is warranted to elucidate mode of action and evaluate impact relative to an antibiotic-containing positive control.
Stress in pre-ruminant calves can impact the functionality of the gastric epithelial lining, thereby impacting calf health during times of stress and potentially later in life. To mitigate this challenge, milk replacers frequently contain antibiotics to reduce the proliferation of harmful bacteria that may result in disease in pre-ruminant, milk supplemented calves. However, there is consumer and regulatory pressure to reduce the reliance on these antimicrobials and evaluate alternatives, such as probiotics, that may shift gut bacterial populations without impacting potential antimicrobial resistance. The objective of this study was to determine if supplementing calves with Lactobacillus and Bacillus species in milk replacer impacts pre-ruminant calf health. The project included 44 calves (50% Angus/50% Holstein) in a randomized complete block design, with calf serving as the experimental unit and age serving as a blocking factor. Calves were fed twice daily one of two treatments: 1) milk replacer with Lactobacillus and two Bacillus species at a total rate of 1.25 x 10^9 cfu/head/day; or 2) non-treated milk replacer. There were 22 replicates per treatment. To determine health status, calves were scored daily based on health indicators for fecal consistency or eye, nose, or ear normality. Health scores were ranked from 0 to 3, with 0 representing normal and 3 signaling severe symptoms, such as bilateral eye or nasal discharge, ear droop, or watery feces. Statistical analysis was performed using the GLIMMIX procedure of SAS. Overall, there was no evidence (P > 0.05) that Lactobacillus and Bacillus inclusion impacted any measured health parameter. Notably, approximately 50% of calves had fecal scores indicating some level of watery stool, but this was not impacted (P > 0.05) by probiotics. In summary, the inclusion of probiotics in calf milk replacer did not appear to impact calf health in the first 30 days.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.